Aromadendrin alleviates LPS-induced kidney apoptosis and inflammation by inhibiting phosphorylation of MAPK and NF-κB signaling pathways

• Xiaohong Ma ^[1] ; Wenhua Liu ^[1] ; Bin Wang ^[1] ; Feizhuang Shi ^[1]
  1. [1] Shenzhen Bao’an Authentic TCM Therapy Hospital, Shenzhen, China
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 40, Nº. 2, 2025, págs. 249-258
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Background. Excessive inflammation and apoptosis in kidneys are critical players in the pathogenesis of acute kidney injury (AKI).

    Aromadendrin is a natural flavonoid characterized by anti-inflammatory, anti-apoptotic, and antioxidant actions. Thus, we investigated the roles and mechanisms of aromadendrin in the development of AKI.

    Methods. Lipopolysaccharide (LPS) was used to induce AKI mice, and one hour after LPS challenge, the mice received oral administration of aromadendrin or vehicle. Renal functions were assessed by measuring blood urea nitrogen and creatinine in serum. Histological changes were determined by hematoxylin and eosin staining. Apoptotic cells of renal tissues were detected by TUNEL staining. Gene expression was measured by western blotting and RT-qPCR.

    Results. Aromadendrin alleviated LPS-induced renal dysfunctions and histological defects in mice.

    Additionally, aromadendrin suppressed excessive inflammation and tissue apoptosis in the kidneys of LPSinduced AKI mice. Mechanistically, aromadendrin blocked the activation of NF-κB and MAPK pathways in LPS-induced AKI mice.

    Conclusion. Aromadendrin alleviates LPSstimulated inflammation and tissue cell apoptosis in kidneys by inactivating the NF-κB and MAPK pathways.